FLT3-IN-19
FLT3-IN-19 (Comp 50) is a potent and selective FLT3 inhibitor with IC50 of 0.213 nM. FLT3-IN-19 can be used in AML disease research[1].
Product Specifications
CAS Number
2237234-48-7
UNSPSC
12352005
Target
FLT3
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/flt3-in-19.html
Purity
99.19
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=NNC=C1NC2=NC(C)=NC3=C2CCC3)NC4=CC=C(N5CCNCC5)C=C4
Molecular Formula
C22H26N8O
Molecular Weight
418.49
References & Citations
[1]Yanle Zhi, et al. Discovery of the selective and efficacious inhibitors of FLT3 mutations. Eur J Med Chem. 2018 Jul 15;155:303-315.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL700951V 500 µL Each
Tbl3 Rat shRNA Lentiviral Particle (Locus ID 287120)
Sign In for Pricing
View Details 
K2664102 1.0 µg DNA
ZC3H4 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details